Home Ingredients Brainberry® (Aronia melanocarpa Extract)
CognitiveAntioxidantCardiovascular

Brainberry® (Aronia melanocarpa Extract)

Aronia melanocarpa Nero Eggert variety
Evidence Level
Limited
3 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Branded Aronia melanocarpa (chokeberry) extract from Solabia Nutrition (BioActor BV, Netherlands), standardized to 15-18% anthocyanins (cyanidin-3-O-galactoside as hero compound). Two RCTs in middle-aged adults: 24-week parallel study (n=101 PMC7468716) showed psychomotor speed, focus, cognitive flexibility improvements at 90-150 mg/day; 160 mg/day crossover study (n=30) showed 20% cognitive performance improvement and 10.8% regional cerebral blood flow change. Cyanidin-3-O-galactoside crosses BBB enhancing brain perfusion. US patent for cognitive performance support.

Studied Dose PMC7468716: 90 mg or 150 mg AME daily × 24 wk middle-aged adults. CROSSOVER: 160 mg/day older adults 59-71 y. STANDARD: 90-150 mg/day before breakfast. 15-18% standardized anthocyanins.
Active Compound Cyanidin-3-O-galactoside (Cy3Gal), cyanidin-3-arabinoside, cyanidin-3-xyloside, cyanidin-3-glucoside (anthocyanin glycosides). Standardized to 15-18% total anthocyanins. Nero Eggert variety from Baltic region

Benefits

Long-term cognitive performance in middle-aged adults (PMC7468716)

PMC7468716 randomized double-blind placebo-controlled parallel study in 101 healthy middle-aged overweight adults. 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo for 24 weeks. RESULTS: SIGNIFICANT IMPROVEMENT in psychomotor speed (grooved pegboard test), focus (number cross-out), cognitive flexibility (Stroop test). Brain-derived neurotrophic factor (BDNF) maintenance documented. Foundational long-term RCT. Industry-funded (BioActor BV) but methodologically rigorous double-blind design.

Supported by Trial 1

Brain vascular function + cognition crossover trial (160 mg/day)

Recent crossover study (Clinical Nutrition publication) in 30 healthy overweight/obese older adults aged 59-71 years (BMI 26-31.4). 160 mg AME daily vs placebo. RESULTS: 20% IMPROVEMENT in cognitive performance, 10.8% reduction in regional cerebral blood flow. AME contained 25% anthocyanins (17% cyanidin-3-O-galactoside + 8% other cyanidin glycosides). Confirms vascular function + cognitive synergy. Smaller sample but strong methodology.

Supported by Trial 2

Acute short-term cognitive effects (7 days)

Two RCTs documented Brainberry® cognitive effects after 7-day acute consumption AND long-term 6-12 week consumption. Acute: focus and psychomotor control improvements. Sustained: cognitive flexibility, attention/concentration, reaction time, visual-motor coordination, BDNF maintenance. US patent issued specifically for cognitive performance support claims. Published in peer-reviewed literature (Solabia studies).

Supported by Trial 3, Trial 1

BDNF (brain-derived neurotrophic factor) maintenance

Brainberry® supports OPTIMAL BDNF levels — essential neurotrophin for synaptic plasticity, learning, memory, neuronal survival. BDNF declines with age; maintenance is mechanism for cognitive aging prevention. Distinguishes from acute symptomatic interventions. Mechanism via cyanidin-3-O-galactoside reaching CNS and modulating neurotrophic gene expression.

Supported by Trial 1, Trial 2

Cerebral perfusion enhancement (mechanism)

Cyanidin-3-O-galactoside crosses BBB and SYSTEMICALLY ENHANCES BRAIN PERFUSION + INCREASES OXYGEN UPTAKE per manufacturer characterization. Mechanism for combined cognitive + cerebrovascular benefits. Vascular endothelial function effects via anthocyanin polyphenol mechanisms (NO-mediated). Aronia berries also recognized for vascular protection in older literature.

Supported by Trial 2

Antioxidant + anti-inflammatory CNS effects

Anthocyanins suppress neuroinflammation and oxidative stress in CNS. Modulate pro-inflammatory signaling pathways, scavenge reactive oxygen species, enhance antioxidant defenses. Mechanism contributing to long-term neuroprotection. Aronia melanocarpa is among RICHEST natural sources of cyanidin glycosides — concentrated form via Nero Eggert variety + standardized extraction.

Supported by Trial 1

Mechanism of action

1

Cyanidin-3-O-galactoside BBB penetration (UNIQUE among anthocyanins)

Distinguishing feature: cyanidin-3-O-galactoside (Cy3Gal) is the most BBB-permeable cyanidin glycoside — crosses blood-brain barrier directly to exert CNS effects. Mechanism: galactoside sugar provides distinct membrane transport vs more common glucosides. Aronia melanocarpa naturally contains higher Cy3Gal proportion than other berries. Brainberry® standardization enriches this molecule for cognitive applications.

2

BDNF gene expression maintenance

Anthocyanin metabolites in CNS modulate neurotrophic factor gene expression — particularly BDNF and TrkB pathways. Mechanism for synaptic plasticity preservation, neurogenesis support, and cognitive maintenance with aging. Distinct from acute receptor modulation.

3

Vascular endothelial function and NO production

Anthocyanins improve endothelial function via increased nitric oxide (NO) production. Cerebrovascular effects translate to improved cerebral perfusion and oxygen delivery. Mechanism for combined cognitive + cardiovascular benefits.

4

Antioxidant via direct ROS scavenging

Direct scavenging of reactive oxygen species (hydroxyl, peroxyl, superoxide radicals). Particularly effective in CNS where oxidative stress contributes to age-related cognitive decline. Catechol and phenolic structure of anthocyanins provides electron-donating antioxidant activity.

5

Anti-inflammatory pathway modulation

Suppresses NF-κB, COX-2, iNOS, pro-inflammatory cytokines. Mechanism for chronic inflammation reduction in CNS — relevant to cognitive aging where neuroinflammation contributes to neuronal dysfunction.

6

Procyanidin synergy

Aronia berries also rich in PROCYANIDINS (oligomeric flavonoid polymers) that work synergistically with anthocyanins. Combined polyphenol matrix in Brainberry® provides multi-target effects beyond single-compound activity.

Clinical trials

1
BioActor 24-Week Brainberry® Trial in Middle-Aged Adults (Pivotal)
PubMed

Randomized double-blind placebo-controlled parallel study (PMC7468716, Nutrients 2020).

101 healthy middle-aged overweight adults. Three arms: 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo (maltodextrin). 24-week supplementation period. Cognitive tests: Stroop, grooved pegboard, number cross-out. Vascular function and BDNF measured.

SIGNIFICANT IMPROVEMENTS in psychomotor speed (grooved pegboard), focus (number cross-out), cognitive flexibility (Stroop). Long-term consumption pattern. BDNF maintenance documented. Foundational long-term RCT supporting Brainberry® cognitive claims and US patent. Industry-sponsored (BioActor BV) — important context for evidence interpretation.

2
Brainberry® Crossover Trial — Brain Vascular Function (160 mg/day)
PubMed

Randomized double-blind placebo-controlled crossover study (Maastricht University Medical Center, Clinical Nutrition publication). NCT05268133 COMPLETED.

30 healthy overweight or obese older adults aged 59-71 years (BMI 26-31.4). 160 mg AME daily (containing 25% anthocyanins: 17% cyanidin-3-O-galactoside + 8% other cyanidin glycosides) vs placebo. Brain insulin-sensitivity and vascular function focus.

20% IMPROVEMENT in cognitive performance. 10.8% REDUCTION in regional cerebral blood flow. Brain vascular function improvements documented. Mechanism: cyanidin-3-O-galactoside BBB penetration enabling direct CNS effects. Smaller sample (n=30) but strong crossover methodology in higher-risk older population.

3
Brainberry® Younger Adults 7-Day Acute Trial
PubMed

Randomized double-blind clinical trial in younger subjects (Solabia/BioActor reported study).

Younger subjects, 7-day acute and 12-week long-term consumption protocols.

ACUTE CONSUMPTION: focus and psycho-motor control improvements. SUSTAINED CONSUMPTION: cognitive flexibility, attention/concentration, reaction time, visual-motor coordination improvements. CONFIRMS effects across age groups (younger + older adults). Foundational evidence for US patent issuance.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated — derived from food berry.
GI upset (rare).
Mild allergic reactions in berry-sensitive individuals.
Pregnancy/lactation: limited specific Brainberry® data; whole-food aronia berries safe.
Long-term safety: 24-week trial showed favorable profile; no documented chronic adverse effects.
Anticoagulant interaction theoretical (anthocyanins affect platelet function modestly).

Important Drug interactions

Anticoagulants (warfarin, DOACs): theoretical mild antiplatelet effect — monitor.
Antihypertensives: theoretical mild additive effects via vasodilation.
Statins: compatible; possibly synergistic vascular effects.
Most medications: well-tolerated combination profile.
Iron supplements: theoretical reduced iron absorption (polyphenol-mineral chelation) — separate by 2 hours.

More Cognitive Ingredients

Eye Health
Lutemax® 2020 (Lutein + Both Zeaxanthins — OmniActive)
Lutemax® 2020 is a PATENTED LUTEIN INGREDIENT from MARIGOLD FLOWERS (Tagetes erecta) devel…
Athletic Performance
Creatine Monohydrate
A nitrogen-containing organic acid synthesized in the liver and kidney from arginine, glyc…
Cardiovascular
Fish Oil (EPA + DHA)
Oil extracted from oily fish (anchovy, sardine, mackerel, herring, salmon) — the most stud…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…

Explore Other Ingredients

Cardiovascular
Aronia / Chokeberry (Aronia melanocarpa)
Aronia berry (black chokeberry) is one of the most polyphenol-rich fruits known, particula…
Antioxidant
Pelargonidin
Anthocyanidin pigment giving strawberries, raspberries, red radishes, and pomegranate thei…
Cardiovascular
Hytolive® (Olive Fruit Polyphenols / Hydroxytyrosol)
Hytolive® (PLT Health Solutions) is a natural olive (Olea europaea) fruit polyphenol extra…

Frequently asked questions about Brainberry® (Aronia melanocarpa Extract)

What is the recommended dosage of Brainberry® (Aronia melanocarpa Extract)?

The clinically studied dose for Brainberry® (Aronia melanocarpa Extract) is PMC7468716: 90 mg or 150 mg AME daily × 24 wk middle-aged adults. CROSSOVER: 160 mg/day older adults 59-71 y. STANDARD: 90-150 mg/day before breakfast. 15-18% standardized anthocyanins.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Brainberry® (Aronia melanocarpa Extract) used for?

Brainberry® (Aronia melanocarpa Extract) is studied for long-term cognitive performance in middle-aged adults (pmc7468716), brain vascular function + cognition crossover trial (160 mg/day), acute short-term cognitive effects (7 days). PMC7468716 randomized double-blind placebo-controlled parallel study in 101 healthy middle-aged overweight adults. 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo for 24 weeks.

Are there side effects from taking Brainberry® (Aronia melanocarpa Extract)?

Reported potential side effects may include: Generally extremely well-tolerated — derived from food berry. GI upset (rare). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Brainberry® (Aronia melanocarpa Extract) interact with medications?

Known drug interactions may include: Anticoagulants (warfarin, DOACs): theoretical mild antiplatelet effect — monitor. Antihypertensives: theoretical mild additive effects via vasodilation. Consult a pharmacist or healthcare provider if you take prescription medications.

Is Brainberry® (Aronia melanocarpa Extract) good for cognitive?

Yes, Brainberry® (Aronia melanocarpa Extract) is researched for Cognitive support. PMC7468716 randomized double-blind placebo-controlled parallel study in 101 healthy middle-aged overweight adults. 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo for 24 weeks.